BGM
BGM Group Ltd.Company with tickers: BGM
Market Cap
$75.25M
Shares Outstanding
35,750,000
CIK
1779578
CUSIP
G7307E123
Website
Visit website
Investor Relations
Investor relations
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $14,311,414 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| Interest & Dividend Income | — | ||||
| Net Interest Income | — | ||||
| Noninterest Income | — | ||||
| Total Net Revenue | — | ||||
| Premiums Earned (Net) | — | ||||
| Cost of Revenue | $11,799,981 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| Gross Profit | $2,511,433 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| Operating Expenses | — | ||||
| Research & Development | $528,099 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| Operating Income | $-2,238,307 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| Net Income | $-861,220 | USD | 2025-03-31 | 6-K | 2025-07-24 |
| EPS (Basic) | $-0.03 | USD/shares | 2025-03-31 | 6-K | 2025-07-24 |
| EPS (Diluted) | $-0.03 | USD/shares | 2025-03-31 | 6-K | 2025-07-24 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|---|---|---|
| Oxytetracycline Licorice Products And Tcmd | — | — | — | $40,305,988 | $29,152,228 | $21,961,282 |
| Heparin Products And Sausage Casing | — | — | — | $23,460,467 | $15,318,798 | $2,230,759 |
| Fertilizer | — | — | — | $1,088,570 | $2,000,452 | $905,910 |
| Fertilizer | $549,231 | $701,701 | $486,171 | — | — | — |
| Heparin Products And Sausage Casing | $15,397,503 | $16,729,115 | $23,162,554 | — | — | — |
| Oxytetracycline Licorice Products And Tcmd | $30,149,950 | $32,602,384 | $33,451,159 | — | — | — |